XML 18 R8.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 1 Months Ended 2 Months Ended 3 Months Ended
Jan. 26, 2022
Mar. 31, 2022
Mar. 31, 2023
Cash flows from Operating Activities:      
Net loss $ (37,061) $ (43,378) $ (43,126)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 1,000 21,928 29,374
Stock-based compensation 23,705 32,302 13,925
Noncash lease expense 115 283 436
Change in fair value of warrants 0 13,761 (1,409)
Deferred tax benefits (816) (15,540) (7,373)
Other (9) 1,572 686
Changes in operating assets and liabilities:      
Accounts receivable 11,118 (14,816) 11,282
Prepaids and other assets 1,069 (3,695) (159)
Accounts payable (67,600) 66,091 (810)
Accrued expenses and other liabilities 57,488 (67,637) (4,660)
Long-term earnout liabilities 0 5,595 (10,000)
Deferred revenue 311 3,654 6,182
Other long-term liabilities 77 (30,980) (149)
Net cash used in operating activities (10,603) (30,860) (5,801)
Cash flows from Investing Activities:      
Purchases of property and equipment 0 (1,427) (714)
Capitalized software development costs (441) (1,389) (1,678)
Acquisition of businesses, net of cash acquired 0 (422,974) 0
Net cash used in investing activities (441) (425,790) (2,392)
Cash flows from Financing Activities:      
Proceeds from term loan and line of credit 0 449,000 0
Repayment of term loan 0 (172,488) (5,000)
Payments for financing costs 0 (24,845) 0
Payment of acquisition holdback 0 0 (1,250)
Taxes paid related to net settlement of stock awards 0 0 (2,837)
Redemptions of Class A common stock 0 (510,469) 0
Cash received from the Backstop 0 246,484 0
Distributions to members 0 (463) (45)
Net cash used in financing activities 0 (12,781) (9,132)
Effect of exchange rate changes in cash, cash equivalent and restricted cash (19) 1,697 (44)
Net decrease in cash, cash equivalents and restricted cash (11,063) (467,734) (17,369)
Cash and cash equivalents and restricted cash, beginning of the period 48,639 37,576 39,075
Cash and cash equivalents and restricted cash, end of the period 37,576 49,819 21,706
Reconciliation of cash, cash equivalents and restricted cash to the Condensed Consolidated Balance Sheets:      
Cash and cash equivalents 36,833 42,182 8,267
Restricted cash 743 7,637 13,439
Total cash, cash equivalents and restricted cash 37,576 49,819 21,706
Supplemental cash flow information:      
Cash paid for operating lease liabilities 175 388 0
ROU assets obtained in exchange for operating lease liabilities 7,987 0 0
Capitalized assets financed by accounts payable 0 0 702
Stock-based compensation included in capitalized software development costs 0 0 561
Settlement of incentive plan through issuance of common stock 0 0 1,658
Equity issuance to settle intercompany loan 941 0 0
Deferred consideration for acquisition $ 0 $ 23,500 $ 0